Comparison of the results for three automated immunoassay systems in determining serum HBV markers.

[1]  B. Weber Genetic variability of the S gene of hepatitis B virus: clinical and diagnostic impact. , 2005 .

[2]  A. Tamori,et al.  Quantitative detection of hepatitis B surface antigen by chemiluminescent microparticle immunoassay during lamivudine treatment of chronic hepatitis B virus carriers , 2005, Journal of medical virology.

[3]  M. Chevallier,et al.  Sustained HBs seroconversion during lamivudine and adefovir dipivoxil combination therapy for lamivudine failure. , 2005, Journal of hepatology.

[4]  Sheng-Nan Lu,et al.  Correlation of quantitative assay of hepatitis B surface antigen and HBV DNA levels in asymptomatic hepatitis B virus carriers , 2004, European journal of gastroenterology & hepatology.

[5]  M. Atkins,et al.  Comparison of the ADVIA Centaur and Abbott AxSYM immunoassay systems for a routine diagnostic virology laboratory. , 2004, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[6]  Yoshinori Iwatani,et al.  Quantitation of hepatitis B surface antigen by an automated chemiluminescent microparticle immunoassay. , 2004, Journal of virological methods.

[7]  D. Vlahov,et al.  High prevalence of occult hepatitis B in Baltimore injection drug users , 2004, Hepatology.

[8]  H. Doerr,et al.  Evaluation of Two New Automated Assays for Hepatitis B Virus Surface Antigen (HBsAg) Detection: IMMULITE HBsAg and IMMULITE 2000 HBsAg , 2003, Journal of Clinical Microbiology.

[9]  P. Schneeberger,et al.  Anti-HBs levels after hepatitis B immunisation depend on test reagents: routinely determined 10 and 100 IU/l seroprotection levels unreliable. , 2002, Vaccine.

[10]  D. Samuel,et al.  Antibodies to hepatitis B surface antigen prevent viral reactivation in recipients of liver grafts from anti-HBC positive donors , 2002, Gut.

[11]  H. Doerr,et al.  Hepatitis B virus markers in anti‐HBc only positive individuals * , 2001, Journal of medical virology.

[12]  W. Hop,et al.  Interferon‐alpha therapy for chronic hepatitis B: Early response related to pre‐treatment changes in viral replication , 2001, Journal of medical virology.

[13]  A. Osterhaus,et al.  Serum HBeAg quantitation during antiviral therapy for chronic hepatitis B , 1997, Journal of medical virology.

[14]  Shibo Jiang,et al.  Hepatitis B virus DNA in sera of virus carriers positive exclusively for antibodies to the hepatitis B core antigen , 1991, Journal of medical virology.